We postulate that while peripheral levels of NfL represent the loss of finite pool of neuronal axons, levels of GFAP more likely reflect the turnover of reactive astrocytes carrying out a spectrum of roles in MS lesions. This evidence concerns the gene GFAP and myeloid sarcoma.